≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pneumonia due to Streptococcus pneumoniae

DOID EFO Endpoint Browser PheWeb

J10_PNEUMOPNEUMO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J13
  • Hospital discharge: ICD-9 — 481
  • Hospital discharge: ICD-8 — 48199
  • Cause of death: ICD-10 — J13
  • Cause of death: ICD-9 — 481
  • Cause of death: ICD-8 — 48199

2 out of 7 registries used, show all original rules.

1691

4. Check minimum number of events

None

1691

5. Include endpoints

None

1691

6. Filter based on genotype QC (FinnGen only)

1691

Control definitions (FinnGen only)

Control exclude
J10_INFLUPNEU

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J09-J18
Name in latin
Pneumonia a Streptococco pneumoniae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 18491 7292 10991
Only index persons 14115 5899 8216
Unadjusted period prevalence (%)
Whole population 0.27 0.21 0.31
Only index persons 0.27 0.22 0.31
Median age at first event (years)
Whole population 50.75 54.75 47.87
Only index persons 44.56 49.26 41.19

-FinnGen-

Key figures

All Female Male
Number of individuals 1691 707 984
Unadjusted period prevalence (%) 0.35 0.24 0.43
Median age at first event (years) 54.66 52.46 56.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1515
Matched controls
15148
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J18.9
ICD-10 Finland
Pneumonia, unspecified
68.5
323.0
911
326
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
633.7
323.0
383
8
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4503599627370496.0
323.0
1120
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
216.0
323.0
433
28
48199
ICD-8 Finland
Pneumococcal pneumonia
+∞
224.7
210
*
4810A
ICD-9 Finland
Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]
+∞
195.1
183
*
J01MA14
ATC
moxifloxacin; systemic
9.0
125.5
286
383
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
86.5
360
1000
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
80.4
756
3890
R03BB04
ATC
tiotropium bromide; inhalant
5.6
80.4
256
530
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
5.4
79.7
264
572
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
12.5
79.3
147
129
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.6
76.9
413
1421
J01MA12
ATC
levofloxacin; systemic
3.8
76.1
386
1265
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.3
75.2
319
891
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
70.4
67
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.7
68.3
348
1133
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
341.5
66.0
66
*
H02AB06
ATC
prednisolone; systemic
2.5
61.9
756
4302
R81
ICPC
Pneumonia
13.6
61.5
109
86
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.7
58.6
181
355
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
57.1
333
1187
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
61.3
50.8
59
10
J86.9
ICD-10 Finland
Pyothorax without fistula
81.6
49.2
55
7
R03AC02
ATC
salbutamol; inhalant
2.2
48.8
784
4900
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
46.1
44
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.3
43.1
119
201
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.2
43.1
121
209
A41.9
ICD-10 Finland
Sepsis, unspecified
7.0
42.6
109
166
C03CA01
ATC
furosemide; systemic
2.4
42.2
470
2421
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
40.9
746
4793
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
40.2
194
585
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
8.8
40.2
88
105
R50.9
ICD-10 Finland
Fever, unspecified
3.0
39.9
254
940
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
38.6
260
1000
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
37.9
121
244
J01FA06
ATC
roxithromycin; oral
2.1
37.8
614
3717
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.3
37.6
103
172
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
36.9
167
476
J45.1
ICD-10 Finland
Nonallergic asthma
4.4
36.2
137
331
J47
ICD-10 Finland
Bronchiectasis
15.1
34.2
57
39
R06.0
ICD-10 Finland
Dyspnoea
2.3
33.8
381
1935
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
122.8
33.8
36
*
J46
ICD-10 Finland
Status asthmaticus
7.8
33.3
78
104
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
+∞
32.4
31
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
32.1
178
594
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.6
31.0
150
451
J01CA04
ATC
amoxicillin; systemic
2.0
30.6
1154
9306
R03DA04
ATC
theophylline; systemic, rectal
4.1
30.6
126
330
J01FF01
ATC
clindamycin; systemic
2.1
30.1
426
2382
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
28.1
220
915
J15.8
ICD-10 Finland
Other bacterial pneumonia
286.6
27.8
28
*
R03BA05
ATC
fluticasone; inhalant
2.3
27.6
279
1331
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.6
27.0
129
383
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
27.0
131
394
J96.1
ICD-10 Finland
Chronic respiratory failure
9.3
26.8
56
62
J96.0
ICD-10 Finland
Acute respiratory failure
16.0
26.0
42
27
GD1AD
NOMESCO Finland
Thorax CT examination
5.1
25.7
83
170
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
25.1
24
*
R03BA01
ATC
beclometasone; inhalant
2.5
25.0
216
946
TGC00
NOMESCO Finland
Bronchial lavation
7.0
24.5
61
90
R96
ICPC
Asthma
3.1
23.7
137
469
R03DC03
ATC
montelukast; oral
2.4
23.7
228
1052
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
23.4
168
663
A03
ICPC
Fever
2.3
23.0
233
1106
J01AA02
ATC
doxycycline; systemic
1.8
22.8
1083
8863
WX892
NOMESCO Finland
Monitored bed care
3.0
22.7
135
472
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
22.7
305
1643
SPAT1263
SPAT
Sampling
1.8
22.4
587
4004
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.4
22.3
111
341
H02AB07
ATC
prednisone; oral
2.3
22.1
216
1007
R03AC12
ATC
salmeterol; inhalant
4.1
22.0
89
229
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.6
22.0
102
296
R02
ICPC
Shortness of breath/dyspnoea
2.6
21.9
175
733
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.5
21.8
65
122
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
116.7
21.6
23
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.4
21.5
79
186
R03BB01
ATC
ipratropium bromide; inhalant
4.1
21.4
85
216
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
19.2
21.3
32
17
WX730
NOMESCO Finland
Conventional respirator
7.6
21.3
50
68
R95
ICPC
Chron obstructive pulmonary disease
6.4
20.9
55
88
0382A
ICD-9 Finland
Septicaemia, Pneumococcal septicaemia
+∞
20.9
20
*
ZX120
NOMESCO Finland
Intravenous
2.7
20.5
147
578
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.0
20.1
40
41
H02AB04
ATC
methylprednisolone; systemic
2.2
20.0
214
1037
R03AK07
ATC
formoterol and budesonide; inhalant
2.1
20.0
265
1408
J01DA01
ATC
[U] cefalexin; systemic
1.6
18.6
860
6766
I50.0
ICD-10 Finland
Congestive heart failure
2.9
18.6
118
431
J80
ICD-10 Finland
Adult respiratory distress syndrome
44.6
18.3
22
5
J45.8
ICD-10 Finland
Mixed asthma
5.0
18.3
59
122
WX872
NOMESCO Finland
Intensive care
3.4
18.1
91
282
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
18.1
548
3836
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
18.1
194
941
A46
ICD-10 Finland
Erysipelas
2.2
17.9
206
1029
WW200
NOMESCO Finland
Immunization
4.5
17.6
63
145
N05AA02
ATC
levomepromazine; systemic
3.8
17.4
75
205
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.6
17.4
79
226
J45
ICD-10 Finland
Asthma
2.5
17.0
138
580
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
16.9
387
2489
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
16.7
16
*
R03BA02
ATC
budesonide; inhalant
2.0
16.6
234
1270
WX725
NOMESCO Finland
Noninvasive ventilation
3.5
16.5
78
231
J01FA09
ATC
clarithromycin; systemic
1.7
16.5
404
2647
J20
ICD-10 Finland
Acute bronchitis
2.5
16.5
135
570
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
16.1
383
2486
N02AA05
ATC
oxycodone; systemic
2.1
16.1
199
1023
ZXD05
NOMESCO Finland
Urgent procedure
1.7
16.0
418
2787
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
16.0
269
1559
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
33.7
15.7
20
6
C90.0
ICD-10 Finland
Multiple myeloma
7.9
15.6
35
45
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
15.5
175
866
49300
ICD-8 Finland
Asthma, bronchiale
4.7
15.5
53
117
SPAT1255
SPAT
Intravenous administration of medicine
2.8
15.5
104
394
N05BA01
ATC
diazepam; systemic, rectal
2.1
15.4
184
933
WX882
NOMESCO Finland
High dependency care
4.6
15.3
53
119
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.0
15.2
60
153
R03AC13
ATC
formoterol; inhalant
3.0
15.1
88
305
N05CD07
ATC
temazepam; oral
2.1
14.9
185
954
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
6.1
14.9
40
67
R05
ICPC
Cough
1.8
14.8
284
1713
SPAT1262
SPAT
Handing over of treatment supplies
1.8
14.7
260
1532
J01FA15
ATC
telithromycin; oral
2.3
14.5
145
680
120
Kela drug reimbursment
Hypogammaglobulinaemia
151.4
14.5
15
*
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
151.4
14.5
15
*
N03AX16
ATC
pregabalin; oral
1.8
14.5
292
1791
R04.2
ICD-10 Finland
Haemoptysis
4.0
14.4
58
151
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.3
14.2
53
128
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
6.1
14.1
38
64
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.5
14.1
49
111
C07AB07
ATC
bisoprolol; oral
1.5
13.8
618
4691
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
13.8
55
142
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
141.2
13.5
14
*
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
141.2
13.5
14
*
N05CF01
ATC
zopiclone; oral
1.6
13.5
423
2942
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
6.5
13.4
34
53
153
Kela drug reimbursment
Lenalidomid
18.4
13.4
20
11
SPAT1254
SPAT
Administration of medicine
1.9
13.3
197
1086
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
13.3
124
562
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.5
13.1
46
105
N05AH04
ATC
quetiapine; oral
1.9
13.0
206
1163
A07AA02
ATC
nystatin; oral
2.7
12.8
88
338
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
12.7
69
229
J12.8
ICD-10 Finland
Other viral pneumonia
70.5
12.6
14
*
N06AX11
ATC
mirtazapine; oral
1.6
12.5
385
2653
M04AA01
ATC
allopurinol; systemic
1.9
12.5
186
1027
J01DB01
ATC
cefalexin; oral
1.5
12.3
1107
9679
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
12.3
398
2776
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.6
12.3
35
64
N02AX02
ATC
tramadol; systemic, rectal
1.5
12.2
548
4130
JN4AD
NOMESCO Finland
Body CT examination
2.4
12.2
106
465
N05BA04
ATC
oxazepam; oral
1.7
12.1
301
1961
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.0
204
1179
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
12.0
143
723
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
10.1
12.0
23
23
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.7
11.9
39
84
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
6.7
11.7
29
44
L04AX04
ATC
lenalidomide; oral
16.5
11.7
18
11
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.5
11.7
40
90
R06AE07
ATC
cetirizine; oral
1.5
11.7
535
4039
A02BC02
ATC
pantoprazole; systemic
1.5
11.6
824
6808
AA1AD
NOMESCO Finland
CT of head and brain
1.7
11.6
299
1964
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
+∞
11.5
11
*
R03AK08
ATC
formoterol and beclometasone; inhalant
3.4
11.4
55
168
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
5.6
11.3
32
58
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
11.3
215
1289
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
8.4
11.3
24
29
J43.9
ICD-10 Finland
Emphysema, unspecified
6.0
11.2
30
51
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.6
11.2
38
85
N03AX12
ATC
gabapentin; oral
1.8
11.2
188
1082
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
11.1
77
298
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
10.9
179
1019
H02AB09
ATC
hydrocortisone; systemic
4.2
10.9
40
97
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
10.8
59
197
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
10.8
83
342
J01MA02
ATC
ciprofloxacin; systemic
1.5
10.8
497
3739
R03AC03
ATC
terbutaline; inhalant
1.9
10.7
168
944
C03DA01
ATC
spironolactone; oral
2.0
10.6
143
758
N06AA09
ATC
amitriptyline; systemic
2.1
10.6
120
594
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.9
10.6
63
223
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
7.0
10.6
25
36
N05AH03
ATC
olanzapine; systemic
2.5
10.6
79
321
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
10.5
572
4447
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
10.5
911
7757
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.4
366
2589
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
10.3
53
170
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
10.3
70
269
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
10.3
74
294
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
10.3
66
246
A06AD11
ATC
lactulose; oral
1.8
10.2
192
1147
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
10.2
268
1764
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
10.2
327
2264
A10AE04
ATC
insulin glargine; parenteral
2.0
10.1
131
683
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
10.1
160
901
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.4
10.0
29
55
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
5.8
10.0
27
47
GBB00
NOMESCO Finland
Tracheostomy
5.8
10.0
27
47
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.6
10.0
28
51
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.3
9.9
48
148
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
6.0
9.8
26
44
Z2446
NOMESCO Finland
Social worker
2.3
9.8
90
404
C01AA05
ATC
digoxin; systemic
2.1
9.8
118
598
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
10.7
9.8
18
17
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.5
9.8
44
128
JN4BD
NOMESCO Finland
Extensive body CT
2.0
9.8
133
711
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.2
9.7
50
161
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
9.7
286
1933
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
9.7
61
223
GAC46
NOMESCO Finland
Partial decortication of pleura
55.3
9.7
11
*
XW000
NOMESCO Finland
Bone marrow biopsy
2.8
9.6
60
217
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
6.9
9.6
23
34
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
9.6
113
570
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
9.6
300
2061
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.7
9.5
31
67
A41.8
ICD-10 Finland
Other specified sepsis
4.6
9.4
31
68
A02BC01
ATC
omeprazole; systemic
1.5
9.4
345
2459
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
9.4
337
2391
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
9.3
99
476
S97
ICPC
Chronic ulcer skin
2.5
9.3
73
304
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.9
9.2
55
197
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.8
9.1
20
26
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
9.1
98
475
N02BE01
ATC
paracetamol; systemic, rectal
1.4
9.1
1131
10153
348
Kela drug reimbursment
Roflumilast
36.9
9.0
11
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.3
9.0
32
76
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.1
9.0
33
81
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
7.5
8.9
20
27
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
24.2
8.9
12
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.8
194
1215
N06AB04
ATC
citalopram; systemic
1.6
8.8
245
1632
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
8.8
91
434
N03AG01
ATC
valproic acid; systemic, rectal
2.4
8.7
75
327
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.8
8.7
55
202
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.4
8.7
40
119
XG466
NOMESCO Finland
Sleep oxymetry
3.0
8.7
47
158
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
50.3
8.7
10
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.1
8.7
32
79
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.5
8.6
24
44
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
8.6
41
126
N03AE01
ATC
clonazepam; systemic
2.4
8.6
71
303
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.8
8.6
27
57
A02BC03
ATC
lansoprazole; oral
1.5
8.5
343
2487
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
8.5
77
347
J01FA10
ATC
azithromycin; systemic
1.4
8.5
699
5801
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
20.1
8.5
12
6
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.4
8.4
29
67
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
8.4
97
486
TK810
NOMESCO Finland
Hemofiltration
8.6
8.3
17
20
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
5.5
8.3
23
42
F05.9
ICD-10 Finland
Delirium, unspecified
4.2
8.3
30
73
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
8.3
41
130
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
8.2
171
1051
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.2
334
2426
WX704
NOMESCO Finland
Intubation
2.1
8.2
89
434
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
8.1
120
662
C09AA05
ATC
ramipril; oral
1.5
8.1
308
2205
SPAT1260
SPAT
Consultation of another employee
1.6
8.1
213
1399
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
8.2
8.1
17
21
R03DX07
ATC
roflumilast; oral
33.5
8.1
10
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
33.5
8.1
10
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.9
8.1
31
80
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
8.0
107
566
Z3226
NOMESCO Finland
Physiotherapist
1.6
8.0
218
1441
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
8.0
83
396
SPAT1301
SPAT
No procedures
1.4
8.0
392
2953
I50.1
ICD-10 Finland
Left ventricular failure
2.3
8.0
70
310
W19
ICD-10 Finland
Unspecified fall
1.9
7.9
116
637
F10.24
ICD-10 Finland
Alcohol depence active use
4.2
7.9
28
67
127
Kela drug reimbursment
Transplant complication
5.0
7.9
24
49
B01AB05
ATC
enoxaparin; parenteral
1.5
7.9
343
2523
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
7.8
58
236
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.7
7.8
21
37
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
7.8
77
360
J98.1
ICD-10 Finland
Pulmonary collapse
9.5
7.8
15
16
J18
ICD-10 Finland
Pneumonia, organism unspecified
9.5
7.8
15
16
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.0
7.8
18
26
B01AA03
ATC
warfarin; systemic
1.5
7.8
251
1732
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
7.7
46
165
R03AK11
ATC
formoterol and fluticasone; inhalant
3.4
7.7
35
104
A28
ICPC
Limited function/disability NOS
1.7
7.7
161
990
N06AB03
ATC
fluoxetine; oral
1.8
7.7
134
779
N17.8
ICD-10 Finland
Other acute renal failure
5.6
7.7
21
38
Z72.0
ICD-10 Finland
Tobacco use
3.4
7.6
35
105
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
11.9
7.6
13
11
N06AX21
ATC
duloxetine; oral
1.8
7.5
118
667
M05BA04
ATC
alendronic acid; oral
2.0
7.4
90
459
L04AX01
ATC
azathioprine; systemic
2.5
7.4
55
224
WX722
NOMESCO Finland
PEEP
2.3
7.4
69
314
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.0
7.4
88
447
E86
ICD-10 Finland
Volume depletion
3.4
7.3
33
98
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
+∞
7.3
7
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
7.3
7
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
7.2
137
823
ZX108
NOMESCO Finland
Inhalation
7.3
7.2
16
22
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
7.2
54
223
L04AA01
ATC
[U] ciclosporin; systemic
4.4
7.2
24
55
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.1
313
2301
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
7.1
124
726
N07BB01
ATC
disulfiram; oral
2.4
7.1
59
256
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
7.1
46
175
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.1
435
3405
A04AA01
ATC
ondansetron; systemic, rectal
2.1
7.0
72
346
N06AB05
ATC
paroxetine; oral
2.3
7.0
64
291
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.6
7.0
46
177
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.2
6.9
20
39
UGC02
NOMESCO Finland
Rigid bronchoscopy
13.8
6.9
11
8
N05AB01
ATC
dixyrazine; systemic
4.8
6.8
21
44
R03AC18
ATC
indacaterol; inhalant
8.3
6.8
14
17
R05FB02
ATC
cough suppressants and expectorants
1.4
6.8
455
3607
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
6.8
128
764
R06.2
ICD-10 Finland
Wheezing
2.4
6.8
55
237
G00.1
ICD-10 Finland
Pneumococcal meningitis
40.2
6.8
8
*
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
16.8
6.7
10
6
A02BA02
ATC
ranitidine; systemic
1.5
6.7
247
1749
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
4.1
6.7
24
59
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.6
6.7
28
79
N06AA12
ATC
doxepin; systemic
2.2
6.6
64
298
C08CA01
ATC
amlodipine; oral
1.4
6.6
423
3326
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
6.6
61
277
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.3
6.6
11
9
Z3231
NOMESCO Finland
Registered nurse
1.4
6.6
326
2453
J01FA01
ATC
erythromycin; systemic
1.6
6.6
161
1035
J96.9
ICD-10 Finland
Respiratory failure, unspecified
8.7
6.6
13
15
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
6.6
46
182
R29
ICPC
Respiratory symptom/complaint other
2.1
6.5
73
363
N05AX12
ATC
aripiprazole; systemic
2.7
6.5
42
159
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
6.5
122
731
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.5
6.5
21
47
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
6.5
87
465
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.4
208
1434
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
6.4
94
517
N07BA03
ATC
varenicline; oral
2.2
6.4
62
289
R03
ICPC
Wheezing
4.9
6.4
19
39
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
6.3
54
238
N05BA02
ATC
chlordiazepoxide; systemic
2.8
6.3
37
133
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
6.3
76
392
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.3
6.3
12
13
6BA02
NOMESCO Finland
NA
9.3
6.3
12
13
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.1
6.3
9
5
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
6.3
6
*
4829X
ICD-9 Finland
Other bacterial pneumonia, Bacterial pneumonia unspecified
+∞
6.3
6
*
WX726
NOMESCO Finland
High-flow oxygen therapy
+∞
6.3
6
*
J15.4
ICD-10 Finland
Pneumonia due to other streptococci
+∞
6.3
6
*
47099
ICD-8 Finland
Influenza, unqualified
+∞
6.3
6
*
N06AX03
ATC
mianserin; oral
2.3
6.2
56
252
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.3
6.2
21
49
TK800
NOMESCO Finland
Hemodialysis
3.2
6.2
30
95
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
6.2
73
371
R74
ICPC
Upper respiratory infection acute
1.4
6.2
301
2253
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.1
6.2
22
54
N06AX16
ATC
venlafaxine; oral
1.6
6.2
142
899
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.7
6.2
25
69
M10.9
ICD-10 Finland
Gout, unspecified
1.9
6.2
79
417
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.8
6.1
16
28
N05AX08
ATC
risperidone; systemic
1.9
6.1
92
511
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
6.1
72
366
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
2.9
6.1
35
122
D07AA02
ATC
hydrocortisone; topical
1.6
6.1
164
1083
L04AD01
ATC
ciclosporin; systemic
3.6
6.1
25
70
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
12.6
6.1
10
8
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.1
211
1479
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.1
340
2610
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
6.0
121
736
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.0
406
3214
N05CD02
ATC
nitrazepam; oral
3.2
6.0
29
92
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
6.0
65
320

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
763
2868
4.03
169.66
6.0
3.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
103
30
36.50
164.18
1.2
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
510
1591
4.16
144.52
2.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
136
121
12.14
131.85
1.5
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
395
1095
4.40
130.12
2.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
158
184
9.37
126.54
1.8
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
387
1093
4.29
123.92
2.2
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
117
97
12.88
118.44
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
150
178
9.15
118.27
1.8
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
115
94
13.05
117.42
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
121
112
11.56
114.10
1.5
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
173
281
6.74
103.59
3.4
2.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
102
87
12.41
101.28
3.2
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
100
102
10.36
87.97
1.7
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
111
133
8.86
86.51
1.8
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
169
382
4.80
70.25
2.3
1.7
ug/l
3.9
2.4
0.69
152
324
(44790048)
80
84
9.95
68.78
1.6
1.3
—
—
—
0
0
(44806118)
80
84
9.95
68.78
1.7
1.3
—
—
—
0
0
(44790047)
80
84
9.95
68.78
1.7
1.3
—
—
—
0
0
(44790049)
80
84
9.95
68.78
1.7
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
338
1254
3.12
68.42
8.7
7.4
mmol/l
1.4
0.7
2.04
267
961
(3027801) Oxygen [Partial pressure] in Arterial blood
337
1253
3.11
67.92
8.5
7.4
kpa
10.6
12.9
12.70
315
1204
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
337
1253
3.11
67.92
8.5
7.4
kpa
5.0
5.1
0.15
315
1204
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
45
14.26
67.54
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
57
36
16.35
66.88
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
57
37
15.91
65.94
1.6
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
312
1139
3.13
64.68
8.9
7.8
%
94.0
96.2
6.04
292
1104
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
74
79
9.75
62.81
1.7
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
93
134
7.29
61.84
1.5
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
93
134
7.29
61.84
1.5
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
246
825
3.32
58.43
4.7
2.4
g/l
11.1
10.8
0.31
219
757
(3019060) Gas panel - Arterial blood
221
705
3.46
56.79
6.4
5.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
276
1061
2.91
51.47
5.1
3.3
kpa
5.8
5.8
0.25
271
1033
(3002032) Base excess in Venous blood by calculation
273
1052
2.90
50.64
5.1
3.3
mmol/l
2.2
1.7
1.40
226
809
(3008152) Bicarbonate [Moles/volume] in Arterial blood
208
716
3.17
46.90
10.0
7.1
mmol/l
24.3
24.2
0.09
189
668
(3002173) Hemoglobin [Mass/volume] in Arterial blood
267
1060
2.80
46.62
9.6
8.1
g/l
120.8
122.5
0.55
254
1024
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
921
6220
2.06
45.22
8.4
5.8
umol/l
11.4
12.1
0.60
881
5896
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
54
61
9.11
43.84
1.7
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
248
982
2.79
43.35
7.7
6.7
mmol/l
1.7
1.4
1.57
239
949
(3028026) IgM [Mass/volume] in Serum or Plasma
188
652
3.12
41.70
2.2
1.7
g/l
1.1
1.3
1.62
166
602
(42870588) Differential panel, method unspecified - Blood
652
3979
2.04
41.37
8.5
5.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
59
81
7.51
40.85
1.9
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
233
922
2.77
40.66
9.5
8.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
197
717
2.98
40.11
1.9
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
43
40
11.00
40.08
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
72
125
5.97
39.94
3.1
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
61
90
6.99
39.60
1.9
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
894
6164
1.96
39.28
8.8
5.3
e9/l
1.9
2.0
0.28
819
5413
(3024354) Oxygen [Partial pressure] in Venous blood
228
908
2.75
39.24
5.0
2.8
kpa
4.7
4.6
0.42
222
884
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
55
73
7.75
39.20
1.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
55
73
7.75
39.20
1.9
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
55
73
7.75
39.20
1.9
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
897
6201
1.95
39.00
9.0
5.4
e9/l
0.2
0.2
0.73
819
5425
(3027135) IgG subclass 1 [Mass/volume] in Serum
62
96
6.67
38.48
1.5
1.2
g/l
8.4
6.8
0.70
41
65
(4062490)
62
96
6.67
38.48
1.5
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
62
96
6.67
38.48
1.5
1.2
g/l
0.3
0.4
0.57
43
64
(3028192) IgG subclass 2 [Mass/volume] in Serum
62
96
6.67
38.48
1.5
1.2
g/l
2.1
2.9
2.35
42
66
(3001604) Monocytes [#/volume] in Blood
869
5966
1.94
38.33
8.7
5.2
e9/l
0.6
0.6
6.42
775
5124
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
803
5371
1.94
38.28
10.4
5.5
mmol/l
1.2
1.2
4.41
745
4833
(3006315) Basophils [#/volume] in Blood
870
5991
1.93
37.87
8.8
5.2
e9/l
0.0
0.0
1.94
776
5150
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
39
35
11.38
37.20
3.3
3.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
318
1520
2.35
37.10
8.2
5.2
mmol/l
1.1
1.0
0.76
299
1408
(3002030) Lymphocytes/100 leukocytes in Blood
848
5817
1.92
37.07
8.7
5.4
%
24.5
28.6
18.66
804
5397
(3019069) Monocytes/100 leukocytes in Blood
829
5653
1.92
36.81
9.0
5.5
%
8.3
8.8
3.33
787
5263
(3012095) Magnesium [Moles/volume] in Serum or Plasma
359
1824
2.23
36.13
5.2
3.2
mmol/l
0.8
0.8
0.36
337
1707
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
79
166
4.94
35.56
1.6
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
820
5619
1.89
35.41
8.7
5.3
%
2.4
2.9
9.38
779
5199
(3018010) Neutrophils/100 leukocytes in Blood
833
5739
1.89
35.35
8.4
5.2
%
60.5
56.5
14.24
788
5347
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
854
5931
1.89
35.35
10.9
5.9
mmol/l
1.2
1.2
4.67
720
5015
(3042936) Bacteria identified in Isolate by Culture
329
1639
2.25
34.61
2.3
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1001
7355
1.88
34.31
7.4
4.2
mmol/l
6.9
6.7
1.63
948
6846
(3013650) Neutrophils [#/volume] in Blood by Automated count
961
6988
1.87
33.85
13.5
7.7
e9/l
4.8
4.0
11.47
861
6078
(3022096) Basophils/100 leukocytes in Blood
793
5440
1.86
33.53
8.7
5.4
%
0.6
0.7
3.02
747
5045
(3024561) Albumin [Mass/volume] in Serum or Plasma
756
5117
1.86
33.29
6.5
4.6
g/l
33.7
36.0
19.32
706
4771
(3002179) Metamyelocytes/100 leukocytes in Blood
205
859
2.58
31.60
4.5
3.5
%
0.9
0.6
0.76
83
193
(3017181) Myelocytes/100 leukocytes in Blood
218
943
2.51
31.43
4.6
3.7
%
1.1
0.9
0.51
107
264
(3020779) Urea [Moles/volume] in Serum or Plasma
226
997
2.46
31.22
9.4
7.0
mmol/l
10.8
9.7
1.42
214
949
(1616796) Gas panel - Central venous blood
89
228
4.06
31.21
5.2
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
177
696
2.72
30.97
7.2
3.3
mmol/l
2.3
1.4
2.93
140
492
(3014576) Chloride [Moles/volume] in Serum or Plasma
296
1477
2.22
30.72
9.6
6.4
mmol/l
103.6
104.7
3.65
289
1441
(3012501) Base excess in Blood by calculation
90
236
3.97
30.57
6.7
4.1
mmol/l
3.0
2.4
0.93
68
143
(3009343) pH of Capillary blood
179
722
2.65
29.75
7.2
3.3
ph
7.4
7.4
1.81
30
88
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
304
1556
2.16
29.51
3.2
2.4
%
21.2
23.7
1.77
248
1343
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
179
730
2.62
29.08
7.2
3.3
kpa
5.2
5.1
1.27
164
676
(3004789) Transferrin [Mass/volume] in Serum or Plasma
319
1675
2.11
28.95
3.1
2.4
g/l
2.2
2.3
2.70
293
1543
(3022948) Iron [Moles/volume] in Serum or Plasma
336
1801
2.08
28.86
3.1
2.4
umol/l
11.7
13.5
3.85
307
1661
(3007853) Bacteria identified in Skin by Aerobe culture
274
1359
2.21
28.73
2.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
72
170
4.38
28.10
2.7
3.1
%
2.9
1.4
0.86
64
138
(3010421) pH of Blood
96
280
3.57
27.96
6.7
3.8
ph
7.4
7.4
0.81
86
233
(3011412) CD3 cells [#/volume] in Blood
51
90
5.81
27.81
2.7
2.4
e9/l
1.2
1.2
0.07
33
45
(3021440) Promyelocytes/100 leukocytes in Blood
203
898
2.43
27.75
4.6
3.7
%
0.2
0.1
0.52
99
238
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
574
3729
1.82
27.55
3.3
2.5
u/l
57.3
58.6
0.10
535
3444
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
43
65
6.76
27.28
3.7
3.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
256
1263
2.21
27.11
5.6
3.9
u/l
239.9
241.1
0.05
241
1195
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
150
585
2.72
26.58
11.5
10.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
203
915
2.38
26.57
4.4
2.3
g/l
67.3
66.9
0.27
178
825
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
529
3388
1.82
26.39
4.0
2.7
ng/l
2059.8
1259.4
3.03
458
2870
(3026008) Bacteria identified in Urine by Culture
526
3365
1.82
26.33
3.6
2.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
553
2.75
26.28
10.3
9.7
mmol/l
24.4
23.9
0.78
133
518
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
141
539
2.76
25.96
3.6
2.4
%
0.7
0.7
0.24
136
518
(46235355) HIV 1 and 2 tests - Meaningful Use set
379
2204
1.93
25.51
1.9
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
532
3445
1.79
25.40
5.8
3.6
ph
7.4
7.4
1.24
128
646
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
67
6.40
25.32
2.0
2.5
%
12.1
15.7
0.53
14
29
(3007930) Methemoglobin/Hemoglobin.total in Blood
124
452
2.88
24.94
5.7
5.5
%
0.9
0.9
0.04
115
428
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
125
458
2.87
24.91
5.7
5.4
%
1.8
1.7
0.69
115
432
(3032080) INR in Blood by Coagulation assay
709
5008
1.72
24.77
12.5
8.5
inr
1.3
1.2
0.59
248
1464
(3037756) Immunofixation for Serum or Plasma
77
213
3.74
24.25
1.8
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
187
849
2.35
24.00
4.8
3.8
%
0.0
0.5
0.64
83
203
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
312
3.20
23.57
1.6
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
663
4676
1.69
22.76
5.0
3.3
ng/l
33.2
69.5
2.07
492
3239
(3024980) IgG subclass 4 [Mass/volume] in Serum
66
172
3.95
22.62
1.9
1.8
g/l
0.6
1.0
1.13
44
138
(3020891) Body temperature
125
482
2.72
22.60
8.5
4.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
38
62
6.25
22.42
2.1
2.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
471
3064
1.74
21.50
2.6
2.1
mg/l
3.1
2.9
0.57
403
2594
(3014007) Fractional oxyhemoglobin in Arterial blood
162
725
2.37
21.43
12.3
9.0
%
92.4
94.4
4.57
162
719
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
202
3.57
20.73
8.2
5.6
iu/ml
594.6
640.4
0.04
14
26
(3004588) Protein electrophoresis panel - Serum or Plasma
165
764
2.29
20.15
4.5
2.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
156
706
2.33
20.09
1.7
1.2
u/ml
186.7
201.2
0.14
141
650
(40760892) CBC W Ordered Manual Differential panel - Blood
422
2710
1.74
19.94
7.0
4.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
122
496
2.57
19.83
2.1
1.7
g/l
1.7
1.5
1.92
102
430
(3023520) Reticulocytes [#/volume] in Blood
193
960
2.14
19.75
3.4
2.5
e9/l
68.8
68.6
0.02
156
751
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
149
666
2.36
19.74
1.8
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1007
8075
1.61
19.56
5.4
4.0
e6/l
139.2
2018.0
1.61
15
121
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
97
356
2.83
19.26
4.1
2.8
u/ml
0.3
0.4
0.50
52
203
(3010503) CD19 cells [#/volume] in Blood
34
58
5.96
19.20
3.3
2.2
e9/l
2.3
0.1
0.59
34
58
(3027945) Reticulocytes/100 erythrocytes in Blood
241
1317
1.97
19.05
3.1
2.5
%
1.9
1.7
1.05
211
1158
(3039000) Anion gap in Blood
75
239
3.24
19.04
7.1
8.2
mmol/l
12.1
11.3
0.85
67
218
(3018572) Chloride [Moles/volume] in Blood
75
240
3.22
18.91
7.1
8.1
mmol/l
104.6
105.8
0.94
67
219
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
34
59
5.86
18.87
2.4
3.0
%
48.1
40.4
—
8
18
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
84
289
3.01
18.74
1.4
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
93
340
2.84
18.60
7.0
6.7
mmol/l
1.5
1.3
0.74
84
297
(40760888) Immunoglobulin light chains.free panel - Serum
74
241
3.17
18.13
6.6
2.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
198
1030
2.04
17.94
3.0
2.2
nmol/l
361.5
369.4
0.14
181
956
(3000494) Fungus identified in Specimen by Culture
245
1373
1.92
17.93
1.7
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
66
202
3.36
17.88
3.4
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1146
9596
1.60
17.57
11.0
6.7
u/l
83.4
78.2
2.46
1099
8977
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
124
538
2.41
17.54
5.7
3.6
mmol/l
24.1
23.9
0.37
109
481
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
561
3992
1.61
17.46
4.1
3.1
u/l
45.6
34.5
0.46
528
3794
(3003434) Protein [Mass/volume] in Pleural fluid
46
112
4.19
17.30
1.4
1.5
g/l
34.2
30.8
0.76
38
105
(3034860) Kappa light chains.free [Mass/volume] in Serum
89
331
2.78
17.25
6.5
2.6
mg/l
52.2
47.4
0.36
69
270
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
89
332
2.77
17.15
6.5
2.6
mg/l
80.4
88.7
0.05
69
272
(3024891) Influenza virus A+B Ag [Presence] in Specimen
75
255
3.03
17.09
1.4
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
79
277
2.94
17.05
3.6
2.8
mmol/l
25.4
24.4
1.07
72
241
(21494814) CD8 cells/100 lymphocytes in Specimen
25
35
7.24
16.97
2.4
2.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
25
35
7.24
16.97
2.4
2.3
%
11.9
7.1
0.56
25
35
(40767503) Oxygen content in Capillary blood by calculation
69
226
3.14
16.76
3.8
2.2
%
15.5
16.6
1.24
36
118
(3043409) Potassium [Moles/volume] in Arterial blood
95
373
2.64
16.58
8.0
4.0
mmol/l
3.9
3.9
0.48
89
347
(3008757) Leukocyte morphology finding [Identifier] in Blood
46
116
4.05
16.52
3.3
3.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
17
10.69
16.45
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
367
2376
1.70
16.45
3.3
2.6
mosm/kgh2o
527.9
564.2
2.31
318
2010
(3023199) Leukocytes [#/volume] in Pleural fluid
42
100
4.28
16.27
1.3
1.4
e6/l
21709.1
1554.0
0.50
34
74
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
43
106
4.14
15.93
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
103
429
2.49
15.92
1.4
1.4
—
7.9
—
0
13
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.42
15.85
2.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.42
15.85
2.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.42
15.85
2.1
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.42
15.85
2.1
1.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
110
475
2.41
15.73
9.4
3.5
mmol/l
25.2
24.6
1.35
104
439
(3022313) Gas panel - Capillary blood
120
541
2.31
15.56
9.1
3.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
16
10.72
15.55
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
35
75
4.74
15.44
2.6
2.2
e6/l
1056.6
650.2
1.43
14
34
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
24
8.42
15.40
2.8
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
433
2970
1.62
15.34
9.5
6.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
100
419
2.47
15.27
2.9
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
14
10
14.11
15.05
1.4
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
177
942
1.98
14.98
3.7
2.6
ng/l
238.7
188.5
0.75
158
852
(3000850) Epithelial cells [#/volume] in Urine
382
2557
1.64
14.88
3.0
2.4
e6/l
5.7
4.7
0.73
337
2244
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
96
400
2.48
14.84
2.8
2.1
ug/l
547.4
427.1
0.26
91
379
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
385
2588
1.63
14.73
2.1
1.7
mg/l
1.4
1.2
1.05
310
1913
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
134
650
2.15
14.55
2.2
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
474
3383
1.56
13.97
3.6
3.0
e6/l
0.6
0.4
1.18
375
2569
(3035880) pH of Pleural fluid
24
40
6.07
13.87
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
60
203
3.03
13.83
1.5
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
51
157
3.32
13.74
1.4
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
61
213
2.93
13.31
4.9
3.4
%
61.0
56.7
2.04
61
213
(3002582) Erythrocytes [#/volume] in Urine
506
3696
1.53
13.30
3.7
3.1
e6/l
39.0
68.6
1.35
404
2859
(3017143) Hepatitis C virus Ab [Presence] in Serum
232
1399
1.76
13.21
1.8
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
336
2240
1.62
13.13
2.0
1.7
nmol/l
1285.2
1173.0
1.28
264
1682
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
32
73
4.45
13.11
2.2
1.2
u/ml
1.1
1.0
0.02
16
28
(3023183) Ammonium ion [Moles/volume] in Plasma
64
232
2.83
13.06
3.5
3.2
umol/l
32.6
35.6
0.55
56
197
(4015189)
16
18
8.96
12.90
3.6
2.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
13
10.85
12.86
1.1
1.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
289
1867
1.66
12.77
2.5
2.1
s
30.0
29.6
0.57
281
1815
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
224
1352
1.76
12.70
3.8
2.7
umol/l
9.4
8.8
0.12
187
1179
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
59
4.81
12.62
1.9
2.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
41
116
3.60
12.58
6.8
7.4
mg/l
11.2
11.5
0.14
36
109
(3030905) Polymorphonuclear cells [#/volume] in Blood
58
205
2.89
12.40
4.5
3.2
e9/l
4.7
4.0
0.87
58
205
(3015736) pH of Urine
608
4677
1.47
12.17
4.3
3.1
—
5.6
—
0
6
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
32
6.31
12.02
2.6
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
337
2294
1.59
11.98
4.7
3.4
ng/l
662.5
477.0
0.31
267
1788
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
497
3691
1.49
11.81
2.5
2.0
u/l
195.4
240.8
0.66
467
3462
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
88
392
2.31
11.77
2.7
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
454
3323
1.50
11.54
4.9
3.6
estimate
0.0
0.0
0.01
163
1110
(3021589) Normoblasts [#/volume] in Blood
694
5521
1.44
11.43
14.7
8.4
e9/l
0.0
0.0
0.12
582
4546
(3017354) Segmented neutrophils/100 leukocytes in Blood
39
114
3.48
11.42
3.3
3.0
%
59.6
54.9
0.50
30
76
(3009261) Glucose [Presence] in Urine by Test strip
762
6167
1.43
11.41
4.5
3.4
estimate
0.0
0.0
0.80
163
1099
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
210
1282
1.73
11.39
4.7
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
753
6090
1.43
11.28
4.6
3.3
estimate
0.0
0.0
0.00
170
1146
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
167
958
1.82
11.20
5.7
3.5
mmol/l
1.2
1.2
0.24
151
816
(3037467) Urinalysis macro (dipstick) panel - Urine
1009
8608
1.43
11.13
5.2
3.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
83
3.91
11.12
1.4
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
93
3.71
10.98
1.6
1.6
promille
1.6
1.3
0.58
25
74
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
74
315
2.41
10.97
1.7
1.4
g/l
0.2
0.2
0.23
65
301
(3021601) Nitrite [Presence] in Urine by Test strip
752
6102
1.42
10.95
5.9
4.5
estimate
0.0
0.0
0.50
172
1160
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
32
5.99
10.87
2.3
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
32
5.99
10.87
2.3
2.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
59
227
2.66
10.79
2.7
2.1
g/l
127.7
133.2
0.83
48
180
(36304419) Bacteria [Presence] in Urine
448
3315
1.48
10.66
3.5
2.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
51
183
2.84
10.65
1.5
1.3
mmol/l
60.5
61.1
0.04
41
152
(3028308) Erythrocytes [#/volume] in Pleural fluid
32
87
3.73
10.43
1.3
1.3
e6/l
39073.0
124705.4
0.68
23
58
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
605
4753
1.42
10.42
4.9
3.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
75
329
2.34
10.41
1.7
1.4
g/l
1.2
1.2
0.50
69
311
(3045788) Cell count panel - Pleural fluid
30
78
3.90
10.41
1.6
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
18
30
6.05
10.40
1.6
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
560
4346
1.43
10.30
4.3
3.5
e6/l
42.2
103.3
2.23
424
3094
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
45
4.94
10.27
1.4
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
336
2359
1.53
10.26
1.9
1.4
g/l
2.3
2.4
0.86
225
1430
(3015377) Calcium [Moles/volume] in Serum or Plasma
525
4032
1.44
10.20
4.1
3.0
mmol/l
2.3
2.4
0.89
473
3526
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
178
1078
1.73
9.91
2.8
2.3
g/l
0.2
0.2
1.34
159
1009
(3001122) Ferritin [Mass/volume] in Serum or Plasma
658
5282
1.40
9.89
3.6
2.7
ug/l
202.3
129.7
3.78
602
4854
(3037522) Nuclear Ab [Titer] in Serum
235
1538
1.61
9.72
1.4
1.3
titre
395.8
466.3
0.42
48
304
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
268
1828
1.55
9.27
1.8
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
141
821
1.78
9.00
4.8
3.8
ng/l
99.6
84.3
0.96
119
715
(3019977) pH of Arterial blood
24
59
4.11
8.99
4.6
2.1
ph
7.4
7.4
—
8
15
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
74
346
2.19
8.88
1.7
1.6
iu/ml
0.0
0.1
0.59
19
54
(3000012) Reticulocyte production index
21
47
4.51
8.84
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
392
2919
1.45
8.80
1.8
1.5
nmol/l
19.7
20.4
0.43
346
2491
(3000492) Spirometry study
186
1178
1.65
8.75
1.7
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
66
298
2.26
8.62
2.5
2.0
mg/l
9.9
11.2
0.65
61
272
(3052592) Norovirus Ag [Presence] in Stool
12
16
7.55
8.42
1.6
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
29
86
3.41
8.36
3.5
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
231
1569
1.55
8.10
19.2
24.2
inr
1.3
1.3
0.07
28
217
(40768806) Pleura Pathology biopsy report
30
93
3.27
8.09
1.2
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
52
218
2.43
8.04
3.1
2.9
nmol/l
0.8
0.8
0.17
44
170
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
109
3.07
8.03
1.2
1.3
—
—
—
0
0
(4010399)
133
790
1.74
7.94
1.6
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
56
3.97
7.89
3.4
2.6
u/ml
830.0
1357.8
0.54
22
56
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
387
2.04
7.70
4.9
2.0
g/l
12.5
10.5
0.84
59
324
(3012441) Differential panel - Pleural fluid
30
96
3.16
7.70
1.3
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
146
903
1.68
7.53
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
161
1024
1.63
7.45
5.1
3.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
413
1.98
7.44
4.8
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
413
1.98
7.44
4.8
2.0
g/l
4.3
3.8
0.56
50
294
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
413
1.98
7.44
4.8
2.0
g/l
7.4
7.3
0.19
52
305
(3013707) Erythrocyte sedimentation rate by Westergren method
1040
9244
1.32
7.09
5.7
3.6
mm/h
17.2
10.9
19.43
980
8510
(3033658) Prothrombin time (PT) actual/Normal
397
3064
1.39
7.09
5.9
3.6
%
87.4
88.8
0.55
383
2990
(3025941) Bacteria identified in Stool by Culture
110
645
1.75
6.89
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
160
2.54
6.87
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
610
5058
1.32
6.75
2.2
1.9
pmol/l
92.3
94.6
0.59
346
2681
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
63
3.52
6.72
1.7
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
28
5.03
6.71
2.1
2.5
u/ml
4511.8
88496.8
—
5
5
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
57
270
2.15
6.69
1.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
162
1061
1.58
6.65
3.0
2.2
ug/l
5.5
7.5
1.47
137
933
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1381
12862
1.40
6.61
27.6
11.6
mg/l
36.9
22.8
25.56
1221
9918
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
88
489
1.84
6.60
2.2
1.8
u/l
38.7
39.7
0.16
73
431
(3017704) Immunofixation for Urine
21
59
3.59
6.60
2.1
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
64
322
2.03
6.43
1.2
1.2
titre
100.0
52.7
—
5
26
(21494890) Protein electrophoresis panel - 24 hour Urine
30
108
2.81
6.33
3.0
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
137
2.59
6.30
1.2
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
413
3269
1.35
6.19
3.7
2.5
umol/l
1635.3
6457.6
2.66
366
2825
(40761536) Microorganisms panel - Urine sediment
162
1079
1.55
6.19
5.2
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
314
2.01
6.13
3.9
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
277
2061
1.41
6.06
3.0
2.7
e6/l
1.8
1.0
1.61
172
1207
(3024928) Oxygen saturation in Venous blood
50
236
2.15
5.96
3.0
2.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
67
354
1.93
5.89
5.5
2.1
g/l
2.7
1.1
1.00
52
302
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
17
45
3.81
5.82
2.3
2.5
ug/l
26.1
211.8
0.48
17
37
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
338
2618
1.36
5.79
1.9
1.7
pmol/l
42804899.6
30645585.3
0.11
271
2170
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
385
1.88
5.78
5.3
2.0
g/l
3.2
3.0
0.62
50
298
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
587
4935
1.29
5.62
2.7
2.2
nmol/l
76.0
76.5
0.15
525
4392
(3034770) Mitochondria Ab [Titer] in Serum
63
332
1.93
5.59
1.3
1.3
—
1305.0
—
0
10
(3000570) Elastase.pancreatic [Mass/mass] in Stool
66
354
1.90
5.56
1.5
1.5
ug/g
308.8
282.1
0.43
32
209
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
171
2.31
5.55
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
178
2.28
5.51
1.5
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
420
3397
1.31
5.33
4.3
3.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
30
4.36
5.30
1.9
2.5
e6/l
106.7
220.0
—
6
10
(3011397) Hemoglobin [Presence] in Urine by Test strip
351
2777
1.33
5.19
4.3
3.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
35
4.03
5.17
4.1
2.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
75
2.96
5.15
3.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
341
2693
1.33
5.10
4.9
3.6
kg/l
1.0
1.0
0.12
42
383
(3017569) Oxygen content in Arterial blood
17
50
3.42
5.03
2.2
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
35
156
2.27
4.84
4.4
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
121
803
1.55
4.74
3.3
2.9
e9/l
4.8
3.9
2.67
94
628
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
285
2215
1.34
4.73
3.3
2.8
mmol/l
2.5
2.4
2.39
248
1949
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
352
1.82
4.72
1.8
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
29
4.16
4.63
1.5
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
52
276
1.91
4.58
1.4
1.3
—
5.4
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
25
4.42
4.56
1.6
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
9
11
8.22
4.56
2.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
61
343
1.81
4.50
3.8
2.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
68
396
1.75
4.46
1.3
1.2
u/ml
0.3
0.5
—
9
36
(3002385) Erythrocyte distribution width [Ratio]
1163
10775
1.25
4.40
27.5
14.7
%
14.1
13.6
19.31
1142
10532
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
215
1617
1.38
4.39
2.1
1.9
%
1.6
1.5
1.09
172
1431
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
59
331
1.81
4.39
5.4
1.8
g/l
36.8
38.3
1.09
47
278
(3042733) HLA Ab [Presence] in Serum
13
35
3.74
4.37
6.0
4.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
12
7.53
4.35
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
12
7.53
4.35
2.3
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
40
3.52
4.33
6.0
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
40
3.52
4.33
6.1
2.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
6
11.71
4.27
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
939
8524
1.23
4.18
4.3
3.0
u/l
68.6
48.9
3.75
884
7959
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
248
1922
1.34
4.18
3.3
2.9
e6/l
2.6
1.9
0.57
142
1076
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
282
1.83
4.00
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
75
2.69
3.99
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
75
2.69
3.99
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
349
1.75
3.98
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
402
4775
0.79
3.98
3.1
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
459
3882
1.25
3.93
4.9
3.9
mg/mmol
17.4
7.2
2.10
325
2504
(3009508) Creatinine [Moles/volume] in Urine
472
4007
1.25
3.90
4.0
3.2
mmol/l
7.5
7.9
0.97
403
3368
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
77
2.62
3.81
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
70
432
1.65
3.76
4.4
3.8
g/l
0.5
0.3
1.18
34
180
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
349
1.72
3.71
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
109
2.31
3.69
3.9
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
30
3.68
3.64
1.0
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
16
56
2.87
3.63
1.6
1.2
u/l
116.2
81.6
0.41
16
50
(3012516) Albumin [Mass/volume] in Urine
435
3687
1.24
3.62
4.0
3.2
mg/l
564.3
232.2
0.73
300
2380
(3004451) EKG impression Narrative
17
62
2.76
3.59
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
59
353
1.70
3.58
1.1
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
9
7.80
3.56
1.3
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
105
2.30
3.53
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
3136
0.77
3.51
2.5
3.0
ug/l
0.8
0.8
0.09
164
2015
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
381
1.65
3.42
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1207
12735
0.82
3.38
4.4
4.3
mmol/l
1.4
1.4
1.37
1112
11736
(3021788) Differential panel - Synovial fluid
38
203
1.89
3.36
1.3
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
53
2.85
3.36
1.5
1.2
u/l
18.7
18.6
0.01
15
47
(3024471) HLA-A [Type]
12
37
3.26
3.34
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
322
1.70
3.33
1.3
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
48
2.93
3.30
1.4
4.4
umol/l
72.6
115.9
—
7
29
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
77
2.48
3.30
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
50
294
1.72
3.25
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1219
12835
0.82
3.25
4.5
4.3
mmol/l
4.5
4.6
4.51
1125
11894
(3044941) Cell count panel - Synovial fluid
35
184
1.92
3.25
1.2
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
104
2.23
3.16
1.1
1.5
%
19.3
25.5
0.56
12
70
(21494755) Public health laboratory ask at order entry panel
91
1300
0.68
3.15
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
39
215
1.83
3.15
4.5
3.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
42
237
1.79
3.15
1.7
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
42
237
1.79
3.15
1.6
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
877
8037
1.19
3.13
3.5
2.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
20
4.52
3.11
1.8
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
62
2.60
3.04
6.9
6.6
u/ml
33.0
42.1
—
5
16
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
87
1244
0.68
3.04
1.6
1.7
—
—
—
0
0
(3013512) EKG study
421
3619
1.22
3.00
4.6
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
249
1.75
2.97
1.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
449
3888
1.21
2.97
3.5
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
154
1173
1.34
2.95
3.4
4.2
ug/l
70.9
20.2
0.45
127
966
(3024932) HLA-DR beta [Type]
11
35
3.16
2.93
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1246
13055
0.83
2.93
4.9
4.8
mmol/l
2.6
2.7
5.30
1142
12022
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
17
4.72
2.92
1.8
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
52
2.71
2.89
1.6
1.6
—
—
—
0
0
(4034850)
64
415
1.56
2.88
14.8
9.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
247
2012
1.27
2.88
1.3
1.2
iu/ml
37.8
30.7
0.42
80
615
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
13
5.40
2.87
1.7
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
654
5876
1.18
2.86
5.9
3.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1383
13260
1.24
2.86
28.9
14.0
mmol/l
139.0
139.7
19.20
1351
12884
(3000475) Leukocytes [#/volume] in Synovial fluid
47
283
1.68
2.84
1.5
1.7
e6/l
19567.9
15099.3
0.28
34
200
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
59
2.56
2.79
1.7
1.6
u/l
3.5
3.7
—
8
29
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
31
3.24
2.77
1.7
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
31
3.24
2.77
2.6
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
42
2.87
2.75
1.9
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
130
976
1.36
2.75
4.1
2.6
ml/min/173m2
52.7
66.6
4.15
54
375
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
226
1.74
2.71
1.8
1.4
u/ml
106.1
124.6
—
8
44
(3023103) Potassium [Moles/volume] in Serum or Plasma
1386
13311
1.23
2.71
28.6
14.1
mmol/l
4.0
4.0
0.00
1353
12909
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
139
1.96
2.70
1.3
1.6
%
71.8
66.1
0.31
13
92
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
51
319
1.62
2.68
7.1
4.4
mg/l
1.6
1.5
0.30
45
289
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
24
3.76
2.67
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
67
2.40
2.63
1.6
1.3
nmol/l
146.1
137.5
0.23
16
67
(1761482) Bacteria [#/volume] in Urine by Culture
50
314
1.61
2.60
5.2
4.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
7
7.16
2.55
1.4
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
7
7.16
2.55
1.4
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
44
2.74
2.55
1.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
44
2.74
2.55
1.7
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
56
2.51
2.53
4.4
2.8
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
7
16
4.39
2.47
1.0
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
12
5.01
2.40
3.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
90
2.12
2.39
1.4
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
140
1088
1.31
2.38
2.6
2.5
u/l
37.8
84.3
0.54
114
950
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
60
405
1.50
2.31
3.4
2.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
35
2.87
2.30
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
53
2.46
2.28
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
53
2.46
2.28
1.7
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
193
1.72
2.27
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
99
2.03
2.26
3.4
3.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
106
1.99
2.26
1.7
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
79
2.16
2.25
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
79
2.16
2.25
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
79
2.16
2.25
1.2
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
9
5.57
2.21
1.8
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
229
1910
1.23
2.19
1.2
1.2
u/ml
11.1
10.8
0.03
73
728
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
14
4.30
2.15
1.0
1.1
—
—
—
0
0
(4198724)
13
55
2.37
2.12
3.2
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
68
2.22
2.11
1.1
1.1
ratio
1.1
1.1
—
6
23
(40768800) Prostate Pathology biopsy report
17
331
0.51
2.11
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
10
5.01
2.07
1.4
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.08
2.07
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.08
2.07
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
82
2.08
2.07
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
55
375
1.48
2.05
2.6
2.3
u/l
748.8
3613.0
1.74
18
154
(3024263) Appearance of Synovial fluid
13
56
2.33
2.05
1.0
1.6
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
22
118
1.88
2.02
1.9
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
240
1.60
1.99
1.4
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
36
225
1.61
1.97
1.3
1.2
u/ml
1.0
2.3
—
6
16
(44813793)
16
77
2.09
1.96
1.1
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
91
1.99
1.95
3.3
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
150
1.74
1.91
1.9
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
58
2.25
1.91
3.7
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
65
2.16
1.88
5.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
59
821
0.71
1.86
1.2
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
28
2.87
1.86
4.5
2.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
40
2.51
1.83
3.6
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1182
12295
0.87
1.83
4.0
3.9
mmol/l
1.4
1.3
1.35
1084
11260
(4094501)
21
365
0.57
1.82
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
246
1.56
1.82
1.7
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
199
1.62
1.81
1.1
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
16
80
2.01
1.80
3.8
3.4
u/ml
25.1
26.3
0.07
16
80
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
264
1.53
1.77
1.6
1.4
e6/l
179.5
711.4
0.45
34
217
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
264
1.53
1.77
1.6
1.4
e6/l
42.1
14.1
0.50
33
209
(3000330) Specific gravity of Urine by Test strip
83
631
1.33
1.71
4.8
3.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
31
2.59
1.66
1.1
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
87
671
1.31
1.63
4.1
3.5
pmol/l
4.5
4.6
0.27
80
591
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
308
2714
1.16
1.63
1.3
1.2
u/ml
0.6
1.4
3.42
74
698
(3042517) Benzodiazepines panel - Urine
5
14
3.58
1.61
1.0
2.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
26
2.70
1.58
5.4
3.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
32
207
1.56
1.57
1.7
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
129
1.71
1.57
1.3
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
30
192
1.57
1.54
1.3
1.1
u/ml
7.6
3.1
0.30
11
64
(3009214) Lutropin [Units/volume] in Serum or Plasma
51
365
1.41
1.54
1.4
1.5
u/l
11.1
8.1
0.77
41
302
(3036071) Salmonella sp Ab [Titer] in Serum
0
44
0.00
1.51
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
21
2.86
1.50
2.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
64
479
1.35
1.49
3.3
2.2
—
—
—
0
0
(1002224) Polysomnography panel
37
534
0.69
1.48
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1211
12519
0.88
1.48
4.8
4.4
mmol/l
6.1
5.9
3.59
1107
11379
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
147
1.64
1.47
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
147
1.64
1.47
1.8
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
38
2.38
1.45
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
148
1.63
1.44
1.8
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
24
149
1.62
1.41
1.8
1.3
—
—
—
0
0
(3036489) Thrombin time
58
432
1.35
1.41
3.6
2.1
s
21.7
21.5
0.10
53
382
(3044290) Cell count panel - Cerebral spinal fluid
36
246
1.47
1.40
1.4
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
39
271
1.45
1.40
2.0
1.9
nmol/l
1.5
0.8
1.59
32
231
(3024522) Salmonella sp identified in Specimen by Organism specific culture
24
150
1.61
1.38
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
24
150
1.61
1.38
1.8
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
158
1.59
1.38
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
940
8959
1.11
1.37
4.6
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
387
4252
0.88
1.36
3.7
4.2
%
22.3
21.6
0.28
176
2037
(4024509)
17
97
1.76
1.35
2.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
80
632
1.28
1.30
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
24
2.51
1.30
1.5
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
24
2.51
1.30
2.0
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
192
1662
1.18
1.30
1.4
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
137
1.61
1.29
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
145
1.59
1.29
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
291
0.61
1.25
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
291
0.61
1.25
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
291
0.61
1.25
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
131
1552
0.83
1.25
5.0
4.4
%
33.5
31.9
0.79
94
1034
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
315
0.63
1.25
1.4
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
25
2.40
1.24
1.3
1.4
—
—
—
0
0
(4035726)
119
991
1.22
1.23
1.5
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
24
155
1.56
1.23
2.0
1.9
—
1706.7
—
0
6
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
12
63
1.91
1.23
3.0
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
196
1.49
1.22
5.2
3.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
101
1.69
1.20
1.3
1.9
u/field
2.5
1.7
—
8
41
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
48
358
1.35
1.19
1.2
1.3
miu/ml
109.4
224.7
1.26
16
167
(3010144) Erythrocytes [#/volume] in Synovial fluid
19
117
1.63
1.18
1.1
1.3
e6/l
146606.3
108837.8
0.09
12
80
(3001019) Free T4 and TSH panel - Serum or Plasma
45
600
0.74
1.17
1.6
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
223
1.44
1.17
1.4
1.3
u/ml
219.5
246.8
0.23
20
138
(3000764) Benzodiazepines [Presence] in Urine
66
518
1.29
1.16
3.2
2.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
8
39
2.06
1.15
2.6
8.5
mmol/l
23.2
25.3
—
8
34
(40761511) CBC panel - Blood by Automated count
1391
13598
1.13
1.14
24.1
11.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
58
1.90
1.12
1.7
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
40
2.00
1.12
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
512
1.28
1.12
3.3
2.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
58
450
1.30
1.12
2.3
3.3
u/ml
169.1
8890.4
0.80
43
382
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
192
1.47
1.11
1.0
1.1
u/ml
14.8
6.9
0.60
14
93
(3051593) INR in Capillary blood by Coagulation assay
10
51
1.97
1.11
3.6
14.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
292
0.65
1.09
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
21
2.38
1.09
1.2
1.9
umol/l
7.7
15.8
—
5
21
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
66
1.82
1.09
2.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
144
1.53
1.09
2.4
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
166
1445
1.16
1.07
2.5
2.4
ug/g
172.3
138.1
0.56
121
1137
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
989
9516
1.09
1.07
4.0
3.7
pmol/l
14.7
14.8
0.61
894
8597
(3003740) Influenza virus B Ag [Presence] in Specimen
30
211
1.43
1.06
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
66
525
1.27
1.06
3.2
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
113
1.60
1.05
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
237
2120
1.14
1.05
1.5
1.5
—
—
—
0
0
(4268621)
19
121
1.58
1.05
2.4
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
33
2.13
1.05
2.6
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
238
1.39
1.03
1.4
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
34
2.06
1.03
3.9
2.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
47
1.92
1.02
1.8
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
529
0.75
1.02
1.6
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
135
1162
1.18
1.01
1.8
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
68
1.77
1.00
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
35
2.00
1.00
1.4
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
49
1.84
0.98
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
65
522
1.26
0.98
3.3
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
54
424
1.28
0.98
1.8
1.6
mu/l
290.5
275.7
0.13
47
391
(40768795) Lymph node Pathology biopsy report
17
108
1.58
0.96
1.3
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
426
1.28
0.95
1.3
1.4
iu/l
30.6
24.7
0.55
37
356
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
39
294
1.33
0.94
1.4
1.2
u/ml
10.6
8.6
—
9
46
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
37
1.90
0.94
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
15
93
1.62
0.94
1.3
1.1
—
60.3
—
0
8
(3022621) pH of Urine by Test strip
96
810
1.20
0.92
2.6
2.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
20
134
1.50
0.92
1.3
1.4
mu/l
78.9
59.0
0.25
15
121
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
211
1.38
0.88
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
500
5307
0.92
0.88
4.1
4.9
ug/l
2.3
3.6
0.93
447
4763
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
291
1.31
0.85
1.4
1.2
u/ml
1.3
2.7
—
6
25
(3019225) pH of Specimen
137
1201
1.15
0.85
7.3
3.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
112
1.52
0.85
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
213
1.37
0.84
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
137
1.47
0.84
1.5
1.3
nmol/l
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
57
1.76
0.83
2.2
2.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
129
1.48
0.83
1.4
1.4
pmol/l
681.1
315.3
0.81
11
106
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
188
1.39
0.83
1.3
1.2
u/ml
5.5
4.4
—
10
79
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
24
171
1.41
0.83
1.1
1.1
—
10.0
—
0
12
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
126
1438
0.87
0.83
1.6
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
28.0
—
0
25
(3003338) MCHC [Mass/volume]
1137
11080
1.08
0.78
30.6
15.6
g/l
331.8
333.5
6.23
1127
10995
(3003327) Ova and parasites identified in Stool by Light microscopy
47
377
1.25
0.76
2.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
47
378
1.25
0.75
1.4
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
54
1.67
0.74
1.7
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
54
1.67
0.74
1.7
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
210
1.34
0.74
1.0
1.1
u/ml
10.7
2.3
0.56
13
81
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
86
737
1.18
0.73
2.0
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
38
1.85
0.73
1.6
1.7
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1161
11875
0.93
0.72
6.6
5.5
mmol/mol
41.2
39.6
5.65
1074
11004
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
56
1.61
0.72
1.0
1.1
iu/ml
489.9
201.3
—
9
56
(44806420)
7
40
1.75
0.71
1.7
2.5
—
—
—
0
0
(4306422)
24
177
1.36
0.71
1.2
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
41
1.71
0.70
2.1
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
59
1.53
0.68
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
66
557
1.19
0.68
2.2
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
26
340
0.76
0.67
1.2
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
188
1.33
0.66
1.0
1.1
u/ml
0.8
1.3
—
9
78
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
237
0.71
0.66
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
237
0.71
0.66
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
111
1.45
0.66
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
62
1.62
0.65
1.2
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
95
1.48
0.64
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
633
0.83
0.64
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
146
1.37
0.63
1.1
1.0
u/ml
3.7
4.7
—
9
56
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
160
1450
1.11
0.63
2.1
2.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
102
0.59
0.62
2.7
1.5
g/l
0.9
1.0
—
6
102
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
42
510
0.82
0.61
2.1
1.7
mg/l
5.5
2.5
0.93
34
355
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
244
0.73
0.60
1.4
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.2
—
1.7
—
0
20
(3004616) Nuclear Ab [Presence] in Serum
20
148
1.36
0.59
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
131
1.38
0.59
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
157
1.34
0.59
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
319
2999
1.08
0.58
3.2
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
173
1585
1.10
0.57
15.3
6.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
158
1.33
0.57
1.0
1.0
u/ml
30.9
2.6
—
9
56
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
75
858
0.87
0.56
2.5
2.4
au/ml
73.0
20.4
—
5
49
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
107
1.41
0.55
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
82
1.47
0.54
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
38
1.58
0.54
1.5
1.3
ug/l
12.7
9.3
—
6
38
(3009542) Hematocrit [Volume Fraction] of Blood
1218
11967
1.06
0.54
24.4
12.9
%
39.2
40.3
3.56
797
8722
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
74
1.49
0.53
2.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
66
1.52
0.52
1.2
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
179
1.29
0.51
1.0
1.1
u/ml
5.1
2.8
—
10
45
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
67
584
1.15
0.51
2.0
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
144
1319
1.10
0.50
2.0
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
30
243
1.24
0.49
1.5
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1180
11596
1.06
0.49
4.8
4.4
mu/l
1.9
2.0
0.54
1076
10576
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
101
1.39
0.49
1.5
1.4
mmol/l
15.3
11.7
—
5
23
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
84
1.43
0.49
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
467
4859
0.95
0.46
1.9
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
341
0.82
0.45
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
284
1.20
0.44
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
24
296
0.81
0.43
1.5
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
31
1.61
0.43
4.4
7.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
106
966
1.10
0.42
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
10
70
1.43
0.41
1.0
1.1
—
9.2
—
0
18
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
58
1.38
0.41
1.4
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
195
1.23
0.40
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
306
1.18
0.40
3.2
2.3
ug/min
153.7
112.3
0.29
29
196
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
36
1.39
0.38
4.4
7.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
37
1.35
0.37
1.8
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
15
116
1.30
0.37
2.1
2.0
nmol/l
28.5
20.5
0.54
15
110
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
125
1.28
0.37
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
69
622
1.11
0.35
2.6
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
2.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
167
0.78
0.34
1.1
1.0
u/ml
1.2
2.0
—
5
74
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
137
1.24
0.32
1.0
1.0
u/ml
0.2
0.5
—
6
36
(3003694) ABO and Rh group [Type] in Blood
348
3606
0.96
0.31
1.6
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
53
1.32
0.31
1.3
1.1
miu/ml
1256.3
1594.0
—
7
53
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
138
1.23
0.30
1.5
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
54
1.30
0.30
1.4
1.8
nmol/l
1.9
5.2
—
7
45
(3002256) Pathology report gross observation
150
1590
0.94
0.30
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
55
1.27
0.30
1.9
1.5
—
—
—
0
0
(4146454)
18
148
1.22
0.29
2.3
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
126
1183
1.07
0.29
1.3
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
64
1.25
0.27
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
131
1.22
0.27
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
67
1.19
0.26
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
95
1.27
0.26
2.2
2.4
%
10.9
11.2
0.23
12
95
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
82
763
1.08
0.25
1.2
1.2
iu/ml
102.2
157.4
1.04
29
309
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
49
446
1.10
0.24
1.8
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1450
14587
0.96
0.23
36.2
18.0
g/l
132.1
137.3
26.64
1427
14350
(3008898) HLA-B27 [Presence]
47
429
1.10
0.22
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1450
14583
0.96
0.22
35.8
17.9
e12/l
4.4
4.5
21.39
1418
14149
(3035941) MCH [Entitic mass]
1450
14581
0.96
0.21
35.7
17.8
pg
30.3
30.4
0.54
1429
14344
(3024731) MCV [Entitic volume]
1450
14581
0.96
0.21
35.7
17.8
fl
91.2
90.9
1.77
1429
14345
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
131
1374
0.95
0.21
1.5
1.3
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.1
—
0
8
(3017509) Phencyclidine [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.3
—
8.2
—
0
6
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
328
3370
0.97
0.21
1.7
1.6
mmol/l
1.5
1.4
0.46
269
2825
(40768443) Skin Pathology biopsy report
56
518
1.08
0.20
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1451
14588
0.96
0.20
35.9
17.9
e9/l
7.5
6.6
16.11
1417
14153
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
149
1556
0.95
0.20
1.4
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
15
127
1.18
0.19
1.9
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1450
14573
0.96
0.19
35.9
17.9
e9/l
253.9
245.4
3.94
1419
14180
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
53
1.13
0.18
1.0
1.2
—
10.3
—
0
7
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
69
1.16
0.16
1.0
1.6
ug/l
51.9
11.6
—
8
58
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
292
1.10
0.16
1.8
1.9
iu/l
3.6
4.8
0.70
15
102
(3014051) Protein [Presence] in Urine by Test strip
32
294
1.09
0.14
2.9
2.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
128
0.86
0.13
1.4
1.4
pmol/l
90.1
295.9
—
5
39
(3032773) Endomysium IgG Ab [Titer] in Serum
9
108
0.83
0.13
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
231
1.08
0.10
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
144
1.11
0.10
2.1
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
262
1.07
0.09
1.7
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
57
1.05
0.08
1.5
2.2
u/l
212.3
197.6
—
6
57
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
2.0
2.4
ug/l
2.4
1.4
—
6
52
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
64
1.09
0.08
1.4
1.3
—
81.2
—
0
8
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
66
1.06
0.08
1.4
1.4
—
298.0
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
327
0.95
0.07
2.1
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
49
471
1.04
0.07
2.6
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
85
1.06
0.07
1.9
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
85
1.06
0.07
1.9
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
142
0.91
0.06
1.2
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
46
477
0.96
0.06
2.0
1.8
nmol/l
37.5
39.0
0.24
46
459
(3017446) Testosterone [Moles/volume] in Serum or Plasma
121
1233
0.98
0.06
2.2
2.2
nmol/l
12.2
13.1
0.60
104
1096
(3049717) Cytology report of Urine Cyto stain
53
514
1.03
0.05
3.1
2.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
120
1.08
0.05
1.5
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
81
796
1.02
0.03
1.1
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
148
0.95
0.02
1.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1384
13827
1.01
0.02
15.0
9.3
u/l
27.4
27.6
0.15
1341
13308
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
143
1.05
0.01
1.3
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1216
12148
1.00
0.01
20.4
11.5
ml/min/173m2
82.2
81.6
0.41
1018
9916
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
187
0.96
0.01
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
59
583
1.01
0.01
1.1
1.1
titre
—
126.8
—
0
11
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
184
1.03
0.00
1.7
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
291
1.00
0.00
3.6
3.1
mg/l
43.4
25.7
1.37
23
178
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
218
1.01
0.00
1.9
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
122
0.98
0.00
1.6
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
10
98
1.02
0.00
1.1
1.1
nmol/l
260.0
380.7
—
5
87
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
76
0.92
0.00
2.7
7.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4212803)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
4.3
—
0
6
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.7
—
0
6
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
130
1.00
0.00
1.2
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
10
100
1.00
0.00
1.4
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.7
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.6
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4027681)
7
75
0.93
0.00
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
94
0.96
0.00
1.1
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
75
0.93
0.00
1.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
1184.4
—
0
5
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
67
0.90
0.00
1.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PNEUMOPNEUMO and mortality.

Females

Parameter HR [95% CI] p-value
J10_PNEUMOPNEUMO 2.366 [2.04, 2.74] < 0.001
Birth year 0.994 [0.99, 1.0] 0.19

During the follow-up period (1.1.1998 — 31.12.2019), 1121 out of 4384 females with J10_PNEUMOPNEUMO died.

Males

Parameter HR [95% CI] p-value
J10_PNEUMOPNEUMO 2.825 [2.45, 3.26] < 0.001
Birth year 0.99 [0.98, 1.0] 0.031

During the follow-up period (1.1.1998 — 31.12.2019), 1720 out of 5802 males with J10_PNEUMOPNEUMO died.

Mortality risk

Mortality risk for people of age

years, who have J10_PNEUMOPNEUMO.

N-year risk Females Males
1 0.207% 0.591%
5 1.481% 3.573%
10 3.593% 8.349%
15 6.483% 15.976%
20 11.707% 25.92%

Relationships between endpoints

↥

Index endpoint: J10_PNEUMOPNEUMO – Pneumonia due to Streptococcus pneumoniae

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data